Shinjiro Mori

427 total citations
21 papers, 367 citations indexed

About

Shinjiro Mori is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Shinjiro Mori has authored 21 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in Shinjiro Mori's work include RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Shinjiro Mori is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Shinjiro Mori collaborates with scholars based in Japan. Shinjiro Mori's co-authors include Tamiko Nakajima, Haruo Takeshita, Toshihiro Yasuda, Koichiro Kishi, Yoshimitsu Nakashima, Kazuo Shirouzu, Yutaka Ogata, Reiko Iida, Yasushi Kaneko and Yoshito Akagi and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Shinjiro Mori

20 papers receiving 359 citations

Peers

Countries citing papers authored by Shinjiro Mori

Since Specialization

Citations

This map shows the geographic impact of Shinjiro Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinjiro Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinjiro Mori more than expected).

Fields of papers citing papers by Shinjiro Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinjiro Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinjiro Mori. The network helps show where Shinjiro Mori may publish in the future.

Co-authorship network of co-authors of Shinjiro Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Shinjiro Mori. A scholar is included among the top collaborators of Shinjiro Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinjiro Mori. Shinjiro Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections 2015 ·Journal of Infection and Chemotherapy ·Atsuo Nakamura, Osamu Takasu, Yoshiro Sakai, Teruo Sakamoto, Norio Yamashita, Shinjiro Mori, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	32
2	A case of ileal perforation due to ulcerative colitis with backwash ileitis 2013 ·Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine ·(unknown), Shinjiro Mori, (unknown), Norio Yamashita, (unknown), (unknown), (unknown)	0
3	Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer 2008 ·Journal of Surgical Oncology ·Yutaka Ogata, (unknown), Teruo Sasatomi, Nobuya Ishibashi, Shinjiro Mori, (unknown), Yoshito Akagi, Kazuo Shirouzu	38
4	Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal carcinoma. 2007 ·PubMed ·Yutaka Ogata, Teruo Sasatomi, Shinjiro Mori, (unknown), Nobuya Ishibashi, Yoshito Akagi, (unknown), (unknown), (unknown), Kazuo Shirouzu	20
5	The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer 2006 ·Oncology Reports ·Yutaka Ogata, (unknown), Tomoaki Mizobe, Nobuya Ishibashi, Shinjiro Mori, Yoshito Akagi, Satoru Ikeda, (unknown), (unknown), Kazuo Shirouzu	11
6	Biological features of sporadic colorectal carcinoma with high-frequency microsatellite instability: special reference to tumor proliferation and apoptosis 2004 ·International Journal of Clinical Oncology ·Shinjiro Mori, Yutaka Ogata, Kazuo Shirouzu	15
7	Production and characterization of murine monoclonal anti-human DNase II antibodies, and their use for immunoaffinity purification of DNase II from human liver and urine 2002 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Tamiko Nakajima, Toshihiro Yasuda, Haruo Takeshita, Shinjiro Mori, (unknown), Yasushi Kaneko, (unknown), Koichiro Kishi	1
8	Tissue-Specific in Vivo Inhibition of DNase I Gene Expression by Somatostatin 2001 ·Biochemical and Biophysical Research Communications ·Toshihiro Yasuda, Haruo Takeshita, Misuzu Ueki, Reiko Iida, Tamiko Nakajima, Shinjiro Mori, (unknown), Yasushi Kaneko, Koichiro Kishi	16
9	Molecular, biochemical and immunological analyses of porcine pancreatic DNase I 2001 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Shinjiro Mori, Toshihiro Yasuda, Haruo Takeshita, Tamiko Nakajima, (unknown), (unknown), Yasushi Kaneko, Koichiro Kishi	23
10	Amphibian DNases I are characterized by a C-terminal end with a unique, cysteine-rich stretch and by the insertion of a serine residue into the Ca2+-binding site 2001 ·Biochemical Journal ·Haruo Takeshita, Toshihiro Yasuda, Reiko Iida, Tamiko Nakajima, Shinjiro Mori, (unknown), Yasushi Kaneko, Koichiro Kishi	24
11	Use of Human Recombinant DNase I Expressed in COS-7 Cells as an Immunogen to Produce a Specific Anti-DNase I Antibody 2001 ·PubMed ·(unknown), Toshihiro Yasuda, (unknown), Tamiko Nakajima, Shinjiro Mori, (unknown), Yasushi Kaneko, Reiko Iida, (unknown)	8
12	Amphibian DNases I are characterized by a C-terminal end with a unique, cysteine-rich stretch and by the insertion of a serine residue into the Ca2+-binding site 2001 ·Biochemical Journal ·Haruo Takeshita, Toshihiro Yasuda, Reiko Iida, Tamiko Nakajima, Shinjiro Mori, (unknown), Yasushi Kaneko, Koichiro Kishi	14
13	Rapid Purification of Human DNase I Using Mouse Monoclonal Anti-DNase I Antibodies and Characterization of the Antibodies 2000 ·PubMed ·Tamiko Nakajima, Toshihiro Yasuda, Haruo Takeshita, Yoshimitsu Nakashima, Shinjiro Mori, (unknown), Koichiro Kishi	6
14	Mammalian Deoxyribonucleases I Are Classified into Three Types: Pancreas, Parotid, and Pancreas–Parotid (Mixed), Based on Differences in Their Tissue Concentrations 2000 ·Biochemical and Biophysical Research Communications ·Haruo Takeshita, (unknown), Toshihiro Yasuda, Tamiko Nakajima, Yoshimitsu Nakashima, Shinjiro Mori, (unknown), Koichiro Kishi	61
15	The molecular basis for genetic polymorphism of human deoxyribonuclease II (DNase II): a single nucleotide substitution in the promoter region of human DNase II changes the promoter activity 2000 ·FEBS Letters ·Toshihiro Yasuda, Haruo Takeshita, (unknown), Tamiko Nakajima, Yoshimitsu Nakashima, Shinjiro Mori, (unknown), Koichiro Kishi	18
16	Japanese population data for two STR loci, HumTPO and HumLPL 2000 ·Legal Medicine ·Haruo Takeshita, Shinjiro Mori, Toshihiro Yasuda, (unknown), Tamiko Nakajima, (unknown), Souichi Tsutsumi, (unknown), Yasushi Kaneko, Reiko Iida, Koichiro Kishi	1
17	Structural Requirements of a Human Deoxyribonuclease II for the Development of the Active Enzyme Form, Revealed by Site-Directed Mutagenesis 1999 ·Biochemical and Biophysical Research Communications ·(unknown), Haruo Takeshita, Reiko Iida, Tamiko Nakajima, Osamu Hosomi, Y. Nakashima, Shinjiro Mori, (unknown)	15
18	Molecular, biochemical and immunological studies of hen pancreatic deoxyribonuclease I 1999 ·The International Journal of Biochemistry & Cell Biology ·Yoshimitsu Nakashima, Toshihiro Yasuda, Haruo Takeshita, Tamiko Nakajima, Osamu Hosomi, Shinjiro Mori, Koichiro Kishi	20
19	Simultaneous typing of the STR loci, vWF and HumTPO, using discontinuous polyacrylamide gel electrophoresis 1999 ·Legal Medicine ·Haruo Takeshita, Toshihiro Yasuda, Tamiko Nakajima, Yoshimitsu Nakashima, Shinjiro Mori, (unknown), (unknown)	4
20	Identification of the three non‐identical subunits constituting human deoxyribonuclease II 1998 ·FEBS Letters ·Haruo Takeshita, Toshihiro Yasuda, Reiko Iida, Tamiko Nakajima, Osamu Hosomi, Yoshimitsu Nakashima, Shinjiro Mori, Hiroshi Nomoto, Koichiro Kishi	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact